Alaa Ahmad

2PUBLICATIONS
3CO-AUTHORS
Injury preventionDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 28, 2025
EDP-323, a First-In-Class, Once-Daily, Oral L-Protein Inhibitor for the Treatment of RSV: Results From a Phase 1 Study in Healthy Adults.

Kimberly Elmore, John DeVincenzo, Michael H J Rhodin

|Oct 23, 2024
EDP-938 Has a High Barrier to Resistance in Healthy Adults Experimentally Infected with Respiratory Syncytial Virus.

Rachel Emily Levene, John DeVincenzo, Annie L Conery

Pageof 1